PET/CT Principles and Applications

PET/CT Basics - Pixel Power Duo

• PET (Positron Emission Tomography):
  • Uses radiotracers (e.g., $^{18}$F-FDG) that emit positrons.
  • Positron-electron annihilation produces paired 511 keV gamma rays.
  • Reveals tissue metabolic function.
• CT (Computed Tomography):
  • Utilizes X-rays for detailed anatomical cross-sections.
  • Essential for PET attenuation correction, improving image quality.
• PET/CT Synergy:
  • Hardware fusion of PET's functional data with CT's anatomical map.
  • Enhances diagnostic accuracy and precise localization of disease.

⭐ PET provides functional/metabolic information, while CT provides anatomical localization and attenuation correction.

Radioactive Stars - Tracers & Targets

• Radiotracers: Biologically active molecules with a positron-emitting radionuclide tag.
  • Designed for specific molecular targets or physiological pathways.
• Ideal Properties:
  • Short effective half-life (e.g., $^{18}$F: 110 min).
  • High target-to-background ratio.
  • Minimal toxicity.
• Common PET Radiotracers:
  • $^{18}$F-FDG (Fluorodeoxyglucose): Most widely used.

    ⭐ $^{18}$F-FDG is a glucose analog; its uptake reflects glucose metabolism and is increased in most malignant cells, inflammatory processes, and infections.

  • $^{68}$Ga-DOTATATE: Somatostatin receptor imaging (NETs).
  • $^{18}$F-PSMA: Prostate-Specific Membrane Antigen imaging (Prostate Ca).
  • $^{13}$N-Ammonia: Myocardial perfusion.

Scanner Secrets - How PET/CT Sees

• PET (Positron Emission Tomography):
  • Radiotracer emits positrons ($β^+$).
  • $β^+$ annihilates with an electron ($e^-$).
  • Produces two 511 keV gamma photons, nearly 180° apart.
  • Detected by scintillation crystals (e.g., LSO, BGO).
• CT (Computed Tomography):
  • Provides anatomical map via X-ray attenuation.
• Hybrid Imaging:
  • PET (function) + CT (anatomy) = Precise localization.

⭐ PET relies on coincidence detection of two 511 keV gamma photons produced by positron-electron annihilation.

Clinical Cases - Disease Detectives

• Oncology Powerhouse:
  • Diagnosis: Differentiating benign vs. malignant lesions (e.g., solitary pulmonary nodule).
  • Staging & Restaging: Essential for TNM staging and detecting recurrence.
  • Treatment Response: Assessing therapy effectiveness (e.g., PERCIST criteria).
  • Radiotherapy Planning: Precisely targeting tumors.
• Neurological Insights:
  • Dementia: Early Alzheimer's detection (↓FDG uptake).
  • Epilepsy: Identifying epileptogenic foci for surgery.
• Cardiac Viability: Assessing heart muscle health post-MI.
• Inflammation/Infection:
  • Locating source in Fever of Unknown Origin (FUO).
  • Monitoring large vessel vasculitis.

⭐ PET/CT is the standard of care for staging, restaging, and response assessment in lymphoma (e.g., Hodgkin's and DLBCL).

Pitfalls & Protection - Spotting Gremlins Safely

• Pitfalls:
  • Physiological uptake: Muscle activity, inflammation, infection.
  • Artifacts: Motion, metal attenuation, CT misregistration.
  • Drug-induced uptake: e.g., G-CSF, metformin.
• Radiation Safety (📌 ALARA):
  • Time: Minimize exposure duration.
  • Distance: Maximize distance from source.
  • Shielding: Use lead aprons, barriers.
  • Patient prep: Hydration, frequent bladder voiding.

⭐ Brown Adipose Tissue (BAT) is a common physiological variant causing intense FDG uptake, often seen in supraclavicular, neck, and paraspinal regions, especially in cold or anxious patients. oka

• PET uses radiotracers like ¹⁸F-FDG for functional/metabolic imaging.
• CT provides precise anatomical localization and essential attenuation correction.
• ¹⁸F-FDG, a glucose analog, indicates high glycolytic activity, vital in oncology.
• Main applications: cancer staging/restaging, treatment response, dementia, cardiac viability assessment.
• SUV (Standardized Uptake Value) is a key quantitative measure of tracer uptake.
• Differentiate true lesions from physiological FDG uptake (e.g., brain, brown fat) and inflammation.